US Geriatrician Compensation Reaches $304,411 in Doximity’s 2026 Report

Average annual compensation for US medical geneticists reached $273,826 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in medical genetics.
US medical geneticists recorded average annual compensation of $273,826, according to Doximity’s 2026 Physician Compensation Report. The latest figure provides medical geneticists with a specialty-specific benchmark when evaluating compensation, employment opportunities and the financial expectations associated with their practice.
Key findings
Doximity reports average annual compensation of $273,826 for medical geneticists in its 2026 Physician Compensation Report.
For medical geneticists, the figure provides a useful national reference point within a specialty focused on diagnosing, evaluating and managing inherited and genetic disorders.
The national average should not be interpreted as the compensation every medical geneticist will receive. Individual earnings can vary according to geography, experience, patient complexity, clinical focus, diagnostic responsibilities, practice setting and employment structure.
Medical geneticist compensation reaches $273,826
The $273,826 average establishes a current national compensation benchmark for US medical geneticists.
Medical genetics encompasses the evaluation and management of patients with known or suspected genetic conditions, including inherited disorders, chromosomal abnormalities, metabolic diseases and complex syndromes.
Clinical practice can involve detailed phenotypic assessment, family history evaluation, interpretation of genetic testing and coordination of multidisciplinary care.
Medical geneticists may work with patients across different stages of life, from infants and children with congenital or developmental conditions to adults with inherited disorders or genetic disease risks.
The increasing availability of genomic testing has also expanded the range and complexity of information that may need to be interpreted within clinical genetics practice.
For medical geneticists reviewing their current compensation or considering a new position, the Doximity figure provides a useful specialty-specific reference against which an individual package can be assessed.
What influences medical geneticist compensation?
Medical genetics is a diagnostically complex specialty, meaning patient complexity, diagnostic workload, clinical focus and practice setting can all be important when evaluating individual compensation.
Individual consultations can involve extensive review of medical and family histories alongside interpretation of genetic and genomic test results.
The patient population can also shape workload. A physician specialising in metabolic disorders or complex pediatric genetics may have different clinical responsibilities from one working predominantly with adult genetic conditions.
Academic and research responsibilities may form an important component of some positions, particularly within university medical centres and specialist genetics programmes.
Geography, experience and employment model may further influence compensation, with medical geneticists frequently working within children's hospitals, academic medical centres, health systems and specialist genetics services.
These factors mean the $273,826 national average should be treated as a benchmark rather than an expected salary for every medical geneticist.
What the latest figure means for medical geneticists
For US medical geneticists, $273,826 provides a contemporary national reference point when benchmarking existing compensation or assessing a prospective position.
Physicians should consider headline compensation alongside patient complexity, consultation volumes, diagnostic responsibilities, academic commitments, working hours and productivity expectations.
The precise composition of the role is particularly important. Two medical genetics positions can involve substantially different responsibilities depending on patient population, disease focus, genomic testing workload and the balance between clinical, academic and research activities.
The latest Doximity figure therefore provides medical geneticists with a useful starting point for evaluating compensation while recognising that individual earnings can differ substantially according to the clinical and contractual characteristics of a particular role.
About the data
The Doximity 2026 Physician Compensation Report provides compensation benchmarks across a wide range of US medical and surgical specialties.
The specialty figures represent average compensation and should be treated as national benchmarks. An individual medical geneticist’s compensation may differ according to geography, experience, patient complexity, diagnostic responsibilities, practice setting and other professional factors.
Source
Doximity. Physician Compensation Report 2026.https://www.doximity.com/reports/physician-compensation-report/2026#modal-close
Discover how nuaxia can support your next medical education initiative:
Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector
Contact us on: support@nuaxia.com

Comments